Clinical study on treatment of advanced non-small cell lung cancer with kangliu zengxiao decoction.
- Author:
Ji WU
1
;
Zhen-ye XU
;
Zhong-qi WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Antineoplastic Agents; therapeutic use; Carcinoma, Non-Small-Cell Lung; drug therapy; pathology; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Lung Neoplasms; drug therapy; pathology; Male; Middle Aged; Phytotherapy; Prospective Studies; Single-Blind Method; Treatment Outcome
- From: Chinese Journal of Integrated Traditional and Western Medicine 2010;30(2):137-140
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effect of Kangliu Zengxiao Decoction (KLZX) in treating patients with advanced non-small cell lung cancer (NSCLC).
METHODSSixty-one patients with confirmed diagnosis of NSCLC of IIIa-IV stage were randomly assigned to the treatment group (32 patients) and the control group (29 patients). Both groups were treated with two cycles of chemotherapy NP regimen, while KLZX was given to the treatment group additionally.
RESULTSAs compared with the control group, the improvements in the treatment group was better in terms of majority of clinical symptoms, median survival time, Karnofski score and body weight, also in increasing immune function, decreasing levels of tumor marks (CEA, VEGF, CYFRA21-1) and alleviating hemopoietic and digestive adverse reactions. But the two groups showed insignificant difference in reducing tumor size and stabilizing tumor foci.
CONCLUSIONCombined use of KLZX and chemotherapy has the toxicity reducing and effect enhancing action, is one of the effective approaches for treatment of advanced NSCLC.
